Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Sarcoma 1Genitourinary 1Breast 1

Conditions

Ovarian Neoplasms 4Testicular Neoplasms 3Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Teratoma 2Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Germ Cell Cancer 2Lung Neoplasms 2Kidney Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Radiation Injuries 1Osteosarcoma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Unknown Primary 1Melanoma 1Medulloblastoma 1

Interventions

glutamic acid diethyl ester 1Surveys and Questionnaires 1Glutamine 1Glutamic Acid 1Dietary Supplements 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Amifostine × Genitourinary × Clear all
NCT00078845 2012-10-17

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
24 enrolled
BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Neurotoxicity Syndromes, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡